Tab Adult & adolescent ≥12 yr Erosive reflux esophagitis 40 mg once daily for 4 wk, continue for further 4 wk if esophagitis has not healed or if there are persistent symptom.
Long-term management of patients w/ healed esophagitis to prevent relapse 20 mg once daily.
Symptomatic treatment of GERD in patients w/o esophagitis 20 mg once daily for 4 wk. If symptom control has not been achieved after 4 wk, patient should be further investigated. Once symptoms have resolved, administer 20 mg once daily when needed.
Adult requiring continued NSAID therapy Upper GI symptoms 20 mg once daily.
Gastric ulcers 20 mg or 40 mg once daily for 4-8 wk.
Prevention of gastric & duodenal ulcers in patients at risk 20 mg or 40 mg once daily.
Eradication of H. pylori & H. pylori-associated duodenal ulcer, & prevention of peptic ulcers relapse in patients w/ H. pylori-associated ulcers 20 mg bid in combination w/ 1 g amoxicillin bid & 500 mg clarithromycin bid for 7 days.
Pathological hypersecretory conditions including Zollinger-Ellison syndrome & idiopathic hypersecretion Initially 40 mg bid. Adjust dose 80-160 mg daily. Doses >80 mg daily should be divided & given bid.
Maintenance of haemostasis & prevention of rebleeding of gastric or duodenal ulcers following treatment w/ infusion 40 mg once daily for 4 wk.
Patient w/ severe liver impairment Max: 20 mg daily.
IV Reflux esophagitis 40 mg once daily given as IV inj over a period of at least 3 min or as IV infusion over a period of 10-30 min.
Symptomatic treatment of reflux disease 20 mg once daily. ½ of the reconstituted soln should be given as IV inj over a period of approx 3 min or as IV infusion over a period of 10-30 min.
Healing of gastric ulcer associated w/ NSAID therapy, prevention of gastric & duodenal ulcers associated w/ NSAID therapy 20 mg once daily.
Maintenance of haemostasis & prevention of rebleeding of gastric & duodenal ulcers 80 mg as bolus infusion over 30 min, followed by a continuous IV infusion of 8 mg/hr given over 3 days (72 hr). Treatment duration is usually short & transfer to oral treatment should be made as soon as possible.